Eric Niederhoffer SIU-SOM Making basic science clinically relevant for learners: the biochemistry...
-
Upload
audra-jones -
Category
Documents
-
view
217 -
download
4
Transcript of Eric Niederhoffer SIU-SOM Making basic science clinically relevant for learners: the biochemistry...
Eric Niederhoffer
SIU-SOM
Making basic science clinically relevant for learners: the
biochemistry example
Considerations• Wants and needs
Curriculum design, objectives, goals; USMLE
• Biochemistry as a foreign languageWeb lessons, resource pages, animations
• Resource sessionsComplement self-directed learningApplied to patient caseStart simple, discuss difficultBig picture, relevant detailsOverlap and redundancyBuild upon previous knowledge
• Clinical probes for content and conceptsSelf-assessment questions, examinations
• Glucose metabolism as an example
RBC Structure - size, spectrin, channels
Metabolism - glycolysis (2,3-BPG), pentose phosphate pathway (G6PDH, NADPH), glutathione
Hemoglobin - Genes, heme, Mb/Hb (normal), O2 binding, HbS (defect), fibers (sickling and inflammation)
Red Blood Cell BiochemistryA 4-year-old African boy presents with a 2-day history
of painful extremities.
Red Blood Cell Biochemistry
Eric Niederhoffer
SIU-SOM
RBC Structure - size, spectrin, channels
Metabolism - glycolysis (2,3-BPG), pentosephosphate pathway (G6PDH, NADPH),
glutathione
Hemoglobin - Genes, heme, Mb/Hb (normal), O2 binding,HbS (defect), fibers (sickling and inflammation)
Devlin, T. M. (ed.). 2006. Textbook of biochemistry with clinical correlations, 6th ed. John Wiley & Sons, Inc., New York. This is very good for most of what you need.
Mehta, A. B., and A. V. Hoffbrand. 2000. Haematology at a glance, Blackwell Science, Malden, Mass.
Salway, J. G. 2006. Medical biochemistry at a glance, 2nd ed. Blackwell Science, Malden, Mass. This is very good for general principles and topics, and metabolic pathways and regulation. Good focused clinical correlations.
Students’ Notes
RBC Metabolic Pathways
2,3-BPG
BPG mutase
2,3-BPG phosphatase
PPP
NADPH
6PG
3-7 C metabolites(R5P, F6P, G3P)
G6PDHlactonase6PGDH
CO2
NADP+ + H+
GSH
GSSGGR
GP
H2O2 H2O
Glc
Pyr
G6P
1,3-BPG
3PG
HK
PGI
PK
F6P
G3P
PFK
aldolaseF16BP
DHAP
2PG
PEP
PGK
PGM
enolase
G3PDH
Glycolysis
LactateNo O2
LDH
RBC Metabolic Pathways
2,3-BPG
BPG mutase
2,3-BPG phosphatase
PPP
NADPH
6PG
3-7 C metabolites(R5P, F6P, G3P)
G6PDHlactonase6PGDH
CO2
NADP+ + H+
GSH
GSSGGR
GP
H2O2 H2O
Glc
Pyr
G6P
1,3-BPG
3PG
HK
PGI
PK
F6P
G3P
PFK
aldolaseF16BP
DHAP
2PG
PEP
PGK
PGM
enolase
G3PDH
Glycolysis
LactateNo O2
LDH
Glc: glucose HK: hexokinase G6P: glucose-6-phosphate G6PDH: glucose-6-phosphate dehydrogenase
PGI: phosphoglucose isomerase PFK: phosphofructokinase DHAP: dihydroxyacetonephosphate
BPG: bisphophoglycerate PEP: phosphoenolpyruvate Pyr: pyruvate PK: pyruvate kinase (2 genes, 4 isozymes)
NADP+/NADPH: nicotinamide adenine dinucleotide R5P: ribulose-5-phosphate F6P: fructose-6-phosphate
G3P: glyceraldehyde-3-phosphate GSH: reduced glutathione (GSH = Glu-Cys-Gly) GSSH: oxidized glutathione
LDH: lactate dehydrogenase PPP: pentose phosphate pathway 6PGDH: 6-phosphogluconate dehydrogenase
GR: glutathione reductase GP: glutathione peroxidase 3PG: 3-phosphoglycerate 6PG: 6-phosphogluconate
Defect in HK, PGI, aldolase, or BPG mutase/2,3-BPG phosphatase decreased [2,3-BPG]; defect in PK increased [2,3-BPG]
BPG mutase(or synthase)/2,3-BPG phosphatase is a bifunctional enzyme (one protein, two activities), regulated by hypoxia and T3
MIultiple inositol polyphosphate phosphatase acts on 2,3-BPG to give 2-PG
Fetal Hb - lower affinity for 2,3-BPG compared with adult Hb; 2,3-BPG binds to and stabilizes deoxyHb; it is easily displaced from oxyHb
Common deficiencies: G6PDH - X-linked PGI - autosomal recessive PK - autosomal recessive
Sodium fluoride inhibits enolase, used to preserve blood samples for glucose determinations.
Students’ Notes
Hemoglobin Structure Changes
http://www.mfi.ku.dk/PPaulev/chapter8/images/8-3.jpg
Factors Affecting Binding of O2
Depends on pH ([H+]), CO2, BPG (DPG), Temp
pH BPG or T ; right shift
pH BPG or T ; left shift
Review Questions
• What metabolic pathways are used in erythrocytes?
• What clinical observations would you make concerning patients with SCD?
Metabolism in Skeletal Muscle and Nervous Tissue
• Metabolism in skeletal muscle
• Pathways overview
• Regulation in skeletal muscle
• Metabolism in nervous tissue
• Pathways overview
• Clinical aspects
• Clinical aspects
• Clinical/laboratory findings
• GSD, PDHCD
• Glycogen storage disease type VII
• Pyruvate dehydrogenase complex deficiency
• Inborn errors of metabolism
• Glycolysis
• Glycogenolysis
-oxidation (ketone bodies)
• Krebs (tricarboxylic acid) cycle
• Branched-chain amino acids
• Electron transport chain
• Calcium regulation
• Key enzyme regulation
Metabolism in Skeletal MuscleA 21-year-old woman comes to the physician with pain in her right mid-arm.
A 5-year-old boy is brought to the physician to have sutures removed.
Pathways Overview
Acetyl-CoALactateNo O2
Production of ATP
G6P
GlucoseGlycolysis
Pyruvate
BCAAIle, Leu, Val
Krebscycle
ElectronTransport
Chain
GlycogenGlycogenolysis
Ca2+
PKa Ca2+
PDH
Ca2+
ISDH, KGDH
Fatty acids
-Oxidation
Ketone bodies
Regulation in Skeletal MuscleGlc Glycolysis
GlycogenGlycogenolysis
PDH
PK
PFK-1
cAMP
Acetyl-CoAPyr
F6P
F16BP
PEP
G6PPKA
ACATP
EpAR
PiIMPAMP
Ca2+
PKa PP
Ca2+
PDHPPDHK
PDHP
PDH
NH4+
AMPPi
PFK-2
F26BP
ATPCitrate
Metabolism in Nervous Tissue
• Glycolysis
• Glycogenolysis (stress)
-oxidation (ketone bodies)
• Krebs (tricarboxylic acid) cycle
• Branched-chain amino acids
• Electron transport chain
A 21-year-old woman comes to the physician with pain in her right mid-arm.A 19-year-old man is brought to the emergency department after a diving accident.
A 63-year-old woman is brought to the physician for her “parkinsonism.”
Pathways Overview
Acetyl-CoA
Lactate(glial)
Production of ATP
Glycolysis
G6P
Glucose
Pyruvate
BCAAIle, Leu, Val
Krebscycle
ElectronTransport
Chain
Glycogen
Glycogenolysis
LactateNo O2
Fatty acids
-oxidation
Ketone bodies
Clinical Aspects for Inborn Errors of Metabolism in Muscles
Toxic accumulation disorders
• Protein metabolism disorders (amino acidopathies, organic acidopathies, urea
cycle defects)
• Carbohydrate/intolerance disorders
• Lysosomal storage disorders
Energy production/utilization disorders
• Fatty acid oxidation defects
• Carbohydrate utilization, production disorders (glycogen storage,
gluconeogenesis, and glycogenolysis disorders)
• Mitochondrial disorders
• Peroxisomal disorders
• Metabolic acidosis (elevated anion gap)
• Hypoglycemia
• Hyperammonemia
Clinical Aspects for Inborn Errors of Metabolism in Nervous Tissue
Evidence of familial coincidence
Progressive decline in nervous functioning
Appearance and progression of unmistakable neurologic signs
General symptoms
• State of consciousness, awareness, reaction to stimuli
• Tone of limbs, trunk (postural mechanisms)
• Certain motor automatisms
• Myotatic and cutaneous reflexes
• Spontaneous ocular movements, fixation, pursuit; visual function
• Respiration and circulation
• Appetite
• Seizures
Clinical/Laboratory FindingsClinical findings AA OA UCD CD GSD FAD LSD PD MD
Episodic decompensation X + ++ + X + - - X
Poor feeding, vomiting, failure to thrive
X + ++ + X X + + +
Dysmorphic features and/or skeletal or organ malformations
X X - - X X + X X
Abnormal hair and/or dermatitis - X X - - - - - -
Cardiomegaly and/or arrhythmias - X - - X X + - X
Hepatosplenomegaly and/or splenomegaly
X + + + + + + X X
Developmental delay +/- neuroregression
+ + + X X X ++ + +
Lethargy or coma X ++ ++ + X ++ - - X
Seizures X X + X X X + + X
Hypotonia or hypertonia + + + + X + X + X
Ataxia - X + X - X X - -
Abnormal odor X + X - - - - - -
Laboratory Findings*
Primary metabolic acidosis X ++ + + X + - - X
Primary respiratory alkalosis - - + - - - - - -
Hyperammonemia X + ++ X - + - - X
Hypoglycemia X X - + X + - - X
Liver dysfunction X X X + X + X X X
Reducing substances X - - + - - - - -
Ketones A H A A L/A L A A H/A
Glycogen Storage DiseasePyruvate Dehydrogenase Complex Deficiency
Krebscycle
G6P
Glucose
GlycolysisGlycogenGlycogenolysisGlycogenesis F6P
F16BPPFK
Tarui diseaseGlycogen Storage Disease Type VII
Acetyl-CoAPyruvatePDH
PDH complex deficiency
R5P nucleotides
Pentose Phosphate Pathway
Glycogen Storage Disease Type VII (Tarui Disease)
Classic, infantile onset, Late onset
Exercise intolerance, fatigue, myoglobinuria
Phosphofructokinase• Tetramer of three subunits (M, L, P)
• Muscle/heart/brain - M4; liver/kidneys - L4; erythrocytes - M4, L4, ML3, M2L2, M3L
General symptoms of classic form• Muscle weakness, pronounced following exercise
• Fixed limb weakness
• Muscle contractures
• Jaundice
• Joint pain
Laboratory studies• Increased serum creatine kinase levels
• No increase in lactic acid levels after exercise
• Bilirubin levels may increase
• Increased reticulocyte count and reticulocyte distribution width
• Myoglobinuria after exercise
• Ischemic forearm test - no lactate increase with ammonia increase
Neonatal, infantile, childhood onset
Abnormal lactate buildup (mitochondrial disease)
Pyruvate dehydrogenase complex
• E1 - (thiamine dependent) and subunits, 22 tetramer
• E2 - monomer (lipoate dependent)
• E3 - dimer (riboflavin dependent) common to KGDH and BCAKDH
• X protein - lipoate dependent
• Pyruvate dehydrogenase phosphatase
Nonspecific symptoms (especially with stress, illness, high carbohydrate intake)• Severe lethargy, poor feeding, tachypnea
• Key feature is gray matter degeneration with foci of necrosis and capillary proliferation in the brainstem (Leigh syndrome)
• Infants with less than 15% PDH activity generally die
Developmental nonspecific signs• Mental delays
• Psychomotor delays
• Growth retardation
Laboratory studies• High blood and cerebrospinal fluid lactate and pyruvate levels
• Elevated serum and urine alanine levels
• If E2 deficient, elevated serum AAs and hyperammonemia
• If E3 deficient, elevated BCAA in serum, KG in serum and urine
Pyruvate Dehydrogenase Complex Deficiency
Inborn Errors of Metabolism
Carbohydrates (Glycogen storage diseases)
Amino acids (Maple syrup urine disease)
Organic acids (Alkaptonuria)
Mitochondrial function (Pyruvate dehydrogenase deficiency)
Purines and pyrimidines (Lesch-Nyhan disease)
Lipids (Familial hypercholesterolemia)
Porphyrins (Crigler-Najjar syndromes)
Metals (Hereditary hemochromatosis)
Peroxisomes (X-linked adrenoleukodystrophy)
Lysosomes (GM2 gangliosidoses - Tay Sachs disease)
Hormones (hyperthyroidism)
Blood (Sickle cell disease)
Connective tissue (Marfan syndrome)
Kidney (Alport syndrome)
Lung (1-antitrypsin deficiency)
Skin (Albinism)
Review Questions• How does muscle produce ATP (carbohydrates, fatty
acids, ketone bodies, branched-chain amino acids)?• How is skeletal muscle phosphofructokinase-1 regulated?• What are the key Ca2+ regulated steps?• How does nervous tissue (neurons and glial cells)
produce ATP (carbohydrates, fatty acids, ketone bodies, branched-chain amino acids)?
• How do glial cells (astrocytes) assist neurons?• What are some key clinical features (history, physical,
laboratory test results) associated with defects in metabolism that affect muscles and nervous tissue?
Carbohydrate Metabolism in Diabetes
• For the third example taken from the ERG Unit, what would you choose for the resource session?
A 59-year-old man is brought to the emergency department for evaluation of his semiconsciousness and minimal responsiveness
Carbohydrate Metabolism in Diabetes
• Regulation of glycolysis, glycogenesis, glycogenolysis, gluconeogenesis by insulin/glucagonPFK-2 (PKA, AMP-dependent PK)PK (PKA)PDHGS (PKA, PPK, GSK-3, PP-1)GP (PKA, PPK, PP)PEPCK (glucagon)G6Pase (glucagon)
• Regulatory differences among tissuesLiverMuscleCardiac muscle
• Key clinical features (history, physical, laboratory test results) associated with carbohydrate metabolism that occur in diabetes
Summary
• Remember curriculum wants and needs• Practice new language skills• Use resource sessions effectively
Complement self-directed learningApplied to patient caseStart simple, discuss difficultBig picture, relevant detailsOverlap and redundancyBuild upon previous knowledge
• Clinical probes for content and concepts